No connection

Search Results

ITGR vs LLY

ITGR
Integer Holdings Corporation
NEUTRAL
Price
$84.64
Market Cap
$2.91B
Sector
Healthcare
AI Confidence
85%
LLY
Eli Lilly and Company
NEUTRAL
Price
$958.65
Market Cap
$858.01B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ITGR
29.29
LLY
41.7
Forward P/E
ITGR
11.71
LLY
22.78
P/B Ratio
ITGR
1.66
LLY
32.33
P/S Ratio
ITGR
1.57
LLY
13.16
EV/EBITDA
ITGR
11.17
LLY
27.08

Profitability

Gross Margin
ITGR
27.39%
LLY
83.04%
Operating Margin
ITGR
12.79%
LLY
44.9%
Profit Margin
ITGR
5.55%
LLY
31.67%
ROE
ITGR
6.11%
LLY
101.16%
ROA
ITGR
4.75%
LLY
19.41%

Growth

Revenue Growth
ITGR
5.0%
LLY
42.6%
Earnings Growth
ITGR
52.9%
LLY
51.4%

Financial Health

Debt/Equity
ITGR
0.75
LLY
1.65
Current Ratio
ITGR
3.32
LLY
1.58
Quick Ratio
ITGR
2.05
LLY
0.78

Dividends

Dividend Yield
ITGR
--
LLY
0.68%
Payout Ratio
ITGR
0.0%
LLY
26.14%

AI Verdict

ITGR NEUTRAL

Integer Holdings (ITGR) presents a dichotomy between strong forward-looking earnings potential and weak current market sentiment. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the stock is currently trading almost exactly at its growth-based intrinsic value of $85.26, leaving no margin of safety. While the trailing P/E is high, the Forward P/E of 11.71 and explosive YoY earnings growth of 52.9% suggest a significant valuation correction is underway. However, a bearish technical trend and negative insider sentiment temper the bullish analyst consensus.

Strengths
Exceptional short-term liquidity with a Current Ratio of 3.32
Strong earnings acceleration with 52.9% YoY growth
Attractive Forward P/E (11.71) compared to trailing P/E (29.29)
Risks
Lack of margin of safety as price ($84.64) equals intrinsic value ($85.26)
Stagnant revenue growth (5% YoY) suggesting earnings growth is driven by cost-cutting rather than expansion
Bearish technical trend (0/100) and negative insider sentiment
LLY NEUTRAL

LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.

Strengths
Strong profitability (31.7% margin)
Strong revenue growth of 42.6%
Strong ROE of 101.2%
Risks
High valuation with P/E of 41.7
Premium vs Graham Number ($123.85)
Weak financial trend (Piotroski F-Score: 3/9)

Compare Another Pair

ITGR vs LLY: Head-to-Head Comparison

This page compares Integer Holdings Corporation (ITGR) and Eli Lilly and Company (LLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile